Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore

… Hong Kong, Macau, and Singapore LianBio will receive a $ … Hong Kong, Macau, and Singapore pursuant to the companies’ existing … Hong Kong, Macau, and Singapore, which LianBio had previously … novel therapeutics in Mainland China, Hong Kong, Macau and Singapore, …